5-(4-Chlorophenyl)cyclohexane-1,3-dione, 97.0%, 1g

2-Chloro-m-xylene, 98.0%, 5g

3-(1H-Indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione, 98.0%, 50mg

Butanedioic acid, compd. with 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide (1:1), 98.50%, 5g

Condenseur en spirale, 400 mm, 29/32, 1 pièce

tert-Butyl 6,8-dioxo-2,5-diazaspiro[3.5]nonane-2-carboxylate, 97%, 250mg

Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate, 97.0%, 5g

1-Methoxy-3-methylbutan-2-one, 97%, 100mg

3-((2,5-Dichloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)propan-1-ol, 100mg

4-Chloro-2-(1-piperidino)-5-thiazolecarboxaldehyde, 95.0%, 250mg

7-Bromo-5-chloroindolin-2-one, 95.0%, 1g

2-Pentene (cis- and trans- mixture), 95.0%, 100ml

2-(2-chlorophenyl)-6-methylquinoline-4-carboxylic acid, 95.0%, 5g